PADCEV, KEYTRUDA combination for advanced bladder cancer gets FDA breakthrough therapy status
PADCEV, KEYTRUDA combination : Astellas Pharma and Seattle Genetics said that the combination of PADCEV (enfortumab vedotin-ejfv) and Merck's anti-PD-1 therapy KEYTRUDA (pembrolizumab) has been ... Read More
LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection
Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus (QFT-Plus automated screening solution) on the latter’s ... Read More
Stryker hip lawyers on Recall of Stryker hip implants
What are Stryker Hip Implants? What is Stryker Hip Recall? The Stryker Orthoaedics company announced voluntary recall of the rejuvenate and ABG II modular neck ... Read More